TY - JOUR
T1 - Patient and provider perspectives on delivery of oral cancer therapies
AU - Murphy, Caitlin C.
AU - Lee, Simon J.Craddock
AU - Gerber, David E.
AU - Cox, John V.
AU - Fullington, Hannah M.
AU - Higashi, Robin T.
N1 - Publisher Copyright:
© 2019 Elsevier B.V.
PY - 2019/11
Y1 - 2019/11
N2 - Objective: The introduction of oral cancer therapies presents new challenges to delivery of quality cancer care. Little is known about how patients and providers address and overcome these challenges. We conducted a qualitative study exploring the range of patient and provider perspectives on oral cancer therapies. Methods: We conducted semi-structured interviews with patients and providers at a tertiary referral center and county safety-net hospital in Dallas, TX. Interviews probed perspectives on differences between parenteral chemotherapy and oral therapies, adherence, communication, and cost/insurance. Interview transcripts were analyzed thematically using a deductively-driven coding scheme corresponding to the interview guide. Results: We conducted 22 patient (13 at tertiary referral center, 9 at safety-net hospital) and 10 provider (7 oncologists, 2 nurses, 1 pharmacist) interviews. Key themes from interviews included: (1) differences in parenteral chemotherapy vs. oral therapy; (2) adherence and dosing; and (3) experiences related to cost and communication. Conclusions: Nearly all providers described challenges engaging with and educating patients about oral cancer therapies. Despite our initial hypothesis, safety-net patients encountered few barriers accessing oral therapies compared to patients receiving care in the tertiary referral center. Practice implications: : Our findings will guide future interventions to monitor and support cancer patients receiving oral therapies.
AB - Objective: The introduction of oral cancer therapies presents new challenges to delivery of quality cancer care. Little is known about how patients and providers address and overcome these challenges. We conducted a qualitative study exploring the range of patient and provider perspectives on oral cancer therapies. Methods: We conducted semi-structured interviews with patients and providers at a tertiary referral center and county safety-net hospital in Dallas, TX. Interviews probed perspectives on differences between parenteral chemotherapy and oral therapies, adherence, communication, and cost/insurance. Interview transcripts were analyzed thematically using a deductively-driven coding scheme corresponding to the interview guide. Results: We conducted 22 patient (13 at tertiary referral center, 9 at safety-net hospital) and 10 provider (7 oncologists, 2 nurses, 1 pharmacist) interviews. Key themes from interviews included: (1) differences in parenteral chemotherapy vs. oral therapy; (2) adherence and dosing; and (3) experiences related to cost and communication. Conclusions: Nearly all providers described challenges engaging with and educating patients about oral cancer therapies. Despite our initial hypothesis, safety-net patients encountered few barriers accessing oral therapies compared to patients receiving care in the tertiary referral center. Practice implications: : Our findings will guide future interventions to monitor and support cancer patients receiving oral therapies.
KW - Cancer
KW - Health disparities
KW - Medication adherence
KW - Qualitative research
UR - http://www.scopus.com/inward/record.url?scp=85067581260&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85067581260&partnerID=8YFLogxK
U2 - 10.1016/j.pec.2019.06.019
DO - 10.1016/j.pec.2019.06.019
M3 - Article
C2 - 31239181
AN - SCOPUS:85067581260
SN - 0738-3991
VL - 102
SP - 2102
EP - 2109
JO - Patient Education and Counseling
JF - Patient Education and Counseling
IS - 11
ER -